Hepcinat plus is an direct acting antiviral drug which contain Sofosbuvir 400mg and daclatasvir 60mg as active ingredients. Hepcinat plus is manufactured by Natco Pharma Ltd. Both the drug is prescription depended can be purchased only against a valid prescription of a doctors. It is packed with 28 tablets in a container.
Hepcinat plus, for the treatment of chronic hepatitis C virus (HCV) genotype 1 or 3 infection, with or without ribavirin.
DOSAGE AND ADMINISTRATION :
In adult recommended dosage of Sofosbuvir is 400 mg and daclatasvir is 60 mg and administrated one tablet of Hepcinat plus, orally, once in a day Given with or without food.
For genotype 1
Hepcinat plus, without cirrhosis or with compensated cirrhosis ( child-pugh A)for 12weeks. Hepcinat plus and ribavirin combination is used for decompensated cirrhosis (child – pugh B or C) and Posttransplant
For genotype 3
Hepcinat plus without cirrhosis for 12weeks Hepcinat plus and ribavirin combination used for compensated or decompensated ( child-pugh B or C) cirrhosis and Posttransplant for 12weeks.
( Overdose of Hepcinat plus: No specific antidote available, If overdose occur, patient should be monitor the development of toxicity and supportive and symptomatic care should be monitor. Seek medical emergency or call poison control for immediate treatment. )